Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis
- PMID: 23460423
- PMCID: PMC3636167
- DOI: 10.1002/art.37866
Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis
Abstract
Objective: To compare incidence rates of selected opportunistic infections among children with and children without juvenile idiopathic arthritis (JIA).
Methods: Using U.S. national Medicaid administrative claims data from 2000 through 2005, we identified a cohort of children with JIA based on physician diagnosis codes and dispensed medications. We also identified a non-JIA comparator cohort of children diagnosed as having attention deficit hyperactivity disorder (ADHD). We defined 15 types of opportunistic infection using physician diagnosis or hospital discharge codes; criteria for 7 of these types also included evidence of treatment with specific antimicrobial agents. We calculated infection incidence rates. The rates in the ADHD comparator cohort were standardized to the age, sex, and race distribution of the JIA cohort. We calculated incidence rate ratios (IRRs) with 95% confidence intervals (95% CIs) to compare infection rates.
Results: The JIA cohort included 8,503 children with 13,990 person-years of followup. The ADHD comparator cohort included 360,362 children with 477,050 person-years of followup. When all opportunistic infections were considered together as a single outcome, there were 42 infections in the JIA cohort (incidence rate 300 per 100,000 person-years; IRR 2.4 [95% CI 1.7-3.3] versus ADHD). The most common opportunistic infections among children with JIA were 3 cases of Coccidioides (incidence rate 21 per 100,000 person-years; IRR 101 [95% CI 8.1-5,319] versus ADHD), 5 cases of Salmonella (incidence rate 35 per 100,000 person-years; IRR 3.8 [95% CI 1.2-9.5]), and 32 cases of herpes zoster (incidence rate 225 per 100,000 person-years; IRR 2.1 [95% CI 1.4-3.0]).
Conclusion: Opportunistic infections are rare among children with JIA. Nevertheless, children with JIA had a higher rate of opportunistic infections, including an increased rate of Coccidioides, Salmonella, and herpes zoster compared to children with ADHD.
Copyright © 2013 by the American College of Rheumatology.
Similar articles
-
Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.Rheumatol Int. 2015 Mar;35(3):465-70. doi: 10.1007/s00296-014-3197-6. Epub 2015 Jan 13. Rheumatol Int. 2015. PMID: 25583050
-
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.Arthritis Rheum. 2012 Aug;64(8):2773-80. doi: 10.1002/art.34458. Arthritis Rheum. 2012. PMID: 22569881 Free PMC article.
-
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.Arthritis Rheum. 2012 Apr;64(4):1263-71. doi: 10.1002/art.34348. Epub 2012 Feb 10. Arthritis Rheum. 2012. PMID: 22328538 Free PMC article.
-
Infectious complications in juvenile idiopathic arthritis.Curr Rheumatol Rep. 2013 May;15(5):327. doi: 10.1007/s11926-013-0327-1. Curr Rheumatol Rep. 2013. PMID: 23529583 Review.
-
A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management.Autoimmun Rev. 2023 Jul;22(7):103337. doi: 10.1016/j.autrev.2023.103337. Epub 2023 Apr 15. Autoimmun Rev. 2023. PMID: 37068698 Review.
Cited by
-
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study.Ann Rheum Dis. 2024 Oct 21;83(11):1561-1571. doi: 10.1136/ard-2023-225094. Ann Rheum Dis. 2024. PMID: 38849152 Free PMC article.
-
Immunogenicity and safety of vaccination in children with paediatric rheumatic diseases: a scoping review.Ther Adv Vaccines Immunother. 2023 Apr 25;11:25151355231167116. doi: 10.1177/25151355231167116. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37124959 Free PMC article. Review.
-
Vaccination in children with immune-mediated disorders.J Pediatr (Rio J). 2023 Mar-Apr;99 Suppl 1(Suppl 1):S62-S69. doi: 10.1016/j.jped.2022.11.008. Epub 2022 Dec 21. J Pediatr (Rio J). 2023. PMID: 36566017 Free PMC article. Review.
-
Real-life vaccination coverage in Slovak children with rheumatic diseases.Front Pediatr. 2022 Aug 12;10:956136. doi: 10.3389/fped.2022.956136. eCollection 2022. Front Pediatr. 2022. PMID: 36034574 Free PMC article.
-
Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study.Front Pediatr. 2022 Aug 11;10:917731. doi: 10.3389/fped.2022.917731. eCollection 2022. Front Pediatr. 2022. PMID: 36034561 Free PMC article.
References
-
- Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, et al. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Annals of the rheumatic diseases. 2011;70(4):616–23. Epub 2010/12/24. - PubMed
-
- Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez C, Schaeverbeke T. Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint, bone, spine: revue du rhumatisme. 2011;78(3):279–84. Epub 2011/01/29. - PubMed
-
- Barkley DO, Hohermuth HJ, Howard A, Webster DB, Ansell BM. IgA deficiency in juvenile chronic polyarthritis. J Rheumatol. 1979;6(2):219–24. Epub 1979/03/01. - PubMed
-
- Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011;29(47):8580–4. Epub 2011/09/24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
